Robust Detection Of Minimal Residual Disease In Unselected Patients With B-Cell Precursor Acute Lymphoblastic Leukemia By High-Throughput Sequencing Of IGH

被引：0
作者：
Wu, David
Emerson, Ryan
Sherwood, Anna
Loh, Mignon L.
Angiolillo, Anne
Kirsch, Ilan
Carlson, Christopher S.
Williamson, David
Wood, Brent L.
Robins, Harlan
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2550.2550
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2550
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Aberrant Underexpression of CD81 in Precursor B-Cell Acute Lymphoblastic Leukemia Utility in Detection of Minimal Residual Disease by Flow Cytometry
    Muzzafar, Tariq
    Medeiros, L. Jeffrey
    Wang, Sa A.
    Brahmandam, Archana
    Thomas, Deborah A.
    Jorgensen, Jeffrey L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (05) : 692 - 698
  • [32] Deep Sequencing Approach for Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
    Faham, Malek
    Zheng, Jianbiao
    Moorhead, Martin
    Carlton, Victoria
    Stow, Patricia Lee
    Coustan-Smith, Elaine
    Pui, Ching-Hon
    Campana, Dario
    BLOOD, 2012, 120 (21)
  • [33] Morphological and immunological criteria of minimal residual disease detection in children with B-cell precursors acute lymphoblastic leukemia
    Beznos, O. A.
    Grivtsova, L. Yu
    Popa, A., V
    Shervashidze, M. A.
    Serebtyakova, I. N.
    Tupitsyn, N. N.
    Selchuk, V. U.
    Grebennikova, O. P.
    Titova, G., V
    VI INTERNATIONAL SCIENTIFIC SCHOOL-CONFERENCE OF YOUNG SCIENTISTS MODERN PROBLEMS OF PHYSICS AND TECHNOLOGIES, 2018, 945
  • [34] Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood
    Mussolin, Lara
    Pillon, Marta
    Conter, Valentino
    Piglione, Matilde
    Lo Nigro, Luca
    Pierani, Paolo
    Micalizzi, Concetta
    Buffardi, Salvatore
    Basso, Giuseppe
    Zanesco, Luigi
    Rosolen, Angelo
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5254 - 5261
  • [35] The importance of minimal residual disease for detection of late relapse in B-precursor acute lymphoblastic leukemia
    Virijevic, M.
    Kraguljac-Kurtovic, N.
    Pantic, N.
    Knezevic, V
    Mitrovic, M.
    HIPPOKRATIA, 2022, 26 (01) : 38 - 40
  • [36] Effects of rituximab on the immunophenotype of benign B-cell precursors: Implications for flow cytometric minimal residual disease detection in precursor B-acute lymphoblastic leukemia
    Siami, K
    Awagu, S
    Cooper, DG
    Thomas, SA
    Huh, Y
    Jones, D
    Chen, W
    Jorgensen, JL
    MODERN PATHOLOGY, 2006, 19 : 246A - 247A
  • [37] Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping:: Method and significance
    Dworzak, MN
    Fritsch, G
    Panzer-Grümayer, ER
    Mann, G
    Gadner, H
    LEUKEMIA & LYMPHOMA, 2000, 38 (3-4) : 295 - +
  • [38] Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia (vol 131, pg 1522, 2018)
    Gokbuget, N.
    Dombret, H.
    Bonifacio, M.
    BLOOD, 2019, 133 (24) : 2625 - 2625
  • [39] Minimal residual disease detection in B-cell malignancies by assessing IgH rearrangement
    Maloum, K
    Pritsch, O
    Dighiero, G
    HEMATOLOGY AND CELL THERAPY, 1997, 39 (03) : 119 - 124
  • [40] Effects of rituximab on the immunophenotype of benign B-cell precursors: Implications for flow cytometric minimal residual disease detection in precursor B-acute lymphoblastic leukemia
    Siami, K
    Awagu, S
    Cooper, DG
    Thomas, DA
    Huh, Y
    Jones, D
    Chen, W
    Jorgensen, JL
    LABORATORY INVESTIGATION, 2006, 86 : 246A - 247A
12345